Evidence map›Paper›PMID 11090129›Full record

ArticleGenes & development2000

Dual utilization of an acceptor/donor splice site governs the alternative splicing of the IRF-3 gene.

A Y Karpova, P M Howley, L V Ronco

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Dual-specificity splice sites function alternatively as 5' and 3' splice sites.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

A Y KarpovaDepartment of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA.
P M Howley
L V Ronco
Harvard University · US

Funding

VIRAL EVASION STRATEGIES--ANALYSIS OF THE HERPES VIRUSES HSV,VZV, AND HHV 6 &7P01AI042257 · NIAID · IMMUNE DISEASE INSTITUTE, INC. · PI HOWLEY, PETER M · 1997 to 2000
$990k
STRUCTURE/FUNCTION ANALYSIS OF HPV E6 PROTEINSF32AI009167 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI RONCO, LUCIENNE V · 1994 to 1995
–
NIAID NIH HHS 5 F32 AI09167-02NIAID NIH HHS F32 AI009167NIAID NIH HHS P01 AI042257NIAID NIH HHS P01 AI 42257
6 · The paper itself

Abstract

Interferon regulatory factors constitute a family of transcriptional activators and repressors involved in a large number of vital cellular processes. Interferon regulatory factor-3 (IRF-3) has been implicated in virus and double-stranded RNA mediated induction of IFNbeta and RANTES, in DNA damage signaling, and in virus-induced apoptosis. With its critical role in these pathways, the activity of IRF-3 is tightly regulated in myriad ways. Here we describe novel regulation of IRF-3 at the level of RNA splicing. We show that an unprecedented dual utilization of a splice acceptor/donor site within the IRF-3 mRNA governs the production of two alternative splice isoforms.

Indexed as

Alternative SplicingAmino Acid SequenceBase SequenceCells, CulturedDNA-Binding ProteinsGenomic LibraryHumansInterferon Regulatory Factor-3Molecular Sequence DataNuclear ProteinsPhosphoproteinsProtein BindingRNA-Binding ProteinsSerine-Arginine Splicing FactorsTranscription FactorsDNA-Binding ProteinsInterferon Regulatory Factor-3IRF3 protein, humanNuclear ProteinsPhosphoproteinsRNA-Binding ProteinsSerine-Arginine Splicing FactorsTranscription Factors

Identifiers

PMID11090129
PMCPMC317057
OpenAlexW2123318406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.